Home >  Registry
     
 
Protocol Registry Trial Results IFPMA Background Links
About this Registry

This registry serves as a global repository for information on ongoing Roche Pharmaceuticals Phase II to Phase IV clinical studies, Phase I studies in patients and Roche Diagnostics interventional studies on advanced diagnostic products.

For More Information 

Common Questions
More Frequently Asked Questions 
Overview of Clinical Trials 
Glossary of Terms 
Phase Definitions 
Field Definitions 
Roche Clinical Trial Global Policy 
Site Provided by Thomson CenterWatch

Trial information

PROMPT study: A study of NT-proBNP in an emergency setting

Status: Completed

Protocol number: 21103

Sponsor: Roche Diagnostics Germany GmbH

Company division: Diagnostic

Official Scientific Title: Usefulness of NT-proBNP in the internal emergency department [PROMPT]

Brief summary: This study will investigate the value of NT-proBNP in the management of patients presenting in the emergency department or in the chest pain unit. The influence of the determination of the NT-proBNP value on diagnostic decision-making, and further diagnostic and therapeutic procedures, will be evaluated.

Study type: Interventional; Randomized; Open Label; Placebo; Parallel study

Condition: Heart Disease

Intervention type: Diagnostic Test

Intervention name: proBNP RP Elecsys Kit

Inclusion criteria:

  • patients ≥ 65 years of age;
  • presenting to the internal emergency room or chest pain unit;
  • informed consent.

Exclusion criteria:

  • unambiguously clear symptoms allowing clinician to make decisions without further diagnostic testing.

Gender: Males or Females

Age limits: Min: 65 Years Max: N/A (No limit)

Anticipated start date: January, 2006

Trial registration date: 05/11/2006

Date last updated: 8/19/2008


Link to trial result

This trial was conducted at the following locations:

Germany

  • Berlin
  • Giessen
  • Heidelberg
  • Mainz
  • Munich
  • Regensburg

To contact Roche for more information on this trial please complete the email form below. Treatment decisions and/or suitability for a specific trial are decisions only your healthcare provider can make. If you are patient interested in any of the studies, please have your healthcare provider contact us via this website, and they will be provided with the relevant clinical trial information.

Country*
Are you a:*
Subject*
Last Name*
First Name*
Telephone
E-mail*

your email address is needed for us to reply